首页> 外文会议>IEEE Nuclear Science Symposium and Medical Imaging Conference >An Examination of the Effect of Registration Errors on FDG-PET Evaluation of Chemotherapy Response in Sarcoma
【24h】

An Examination of the Effect of Registration Errors on FDG-PET Evaluation of Chemotherapy Response in Sarcoma

机译:对肉瘤中化疗反应的FDG-PET评估的注册误差探讨

获取原文

摘要

Statistical quantitators that summarise standardized uptake value (SUV) distributions are widely used measures of metabolic activity in the analysis of static Positron Emission Tomography (PET) data. Amongst them, SUV_(mean) and total lesion glycolysis (TLG) have been shown to yield a strong prognostic value for many diseases, which contributed to the rapid expansion of PET-based assessment of diagnosis, prognosis and treatment monitoring methodologies. Such measures, however, remain utilized in a point-wise fashion, that is, without a complementary assessment of their accuracy. Without such information, it is not clear that the assessment would be reliable. This raises important questions in particular for prognosis and therapeutic assessment. We consider here a statistical method that was recently proposed for the monitoring of neoadjuvant chemotherapy for sarcoma. This approach consists in pairing pre- and post-therapy scans in order to quantify the response to therapy, in terms of change in mean tracer uptake, along with an associated estimated accuracy. Pairing the uptake information requires co-registering the two sets of images, which most likely introduces a mis-registration error in the analytic framework. We propose to examine the effect of this mis-registration in a quantified analysis where we formulate the problem as a comparison with a classical (unpaired) therapeutic assessment. We demonstrate that mis-registration should not prevent paired-based methodologies. In particular, the derived measure of assessment accuracy remains more powerful even for large typical mis-registration scales. The viability of this method and its effect on prognostic utility are further considered via multivariate Cox survival analyses on a clinical dataset of 50 sarcoma studies with extensive follow-up information. Encouraging results suggest this approach could generalize to the analysis of other diseases and imaging modalities.
机译:总结标准化摄取值(SUV)分布的统计量表在分析静态正电子发射断层扫描(PET)数据的分析中广泛使用了代谢活动的措施。其中,SUV_(平均值)和总损伤糖酵解(TLG)已被证明对许多疾病产生强烈的预后价值,这有助于培养基于PET的诊断,预后和治疗监测方法的评估。然而,这些措施仍然以点智方式使用,即没有对其准确性的互补评估。没有这样的信息,尚不清楚评估是可靠的。这尤其提出了重要的问题,特别是预后和治疗评估。我们考虑到这里是最近提出用于监测肉瘤的新辅助化疗的统计方法。该方法包括配对预治疗和治疗后扫描,以便在平均示踪吸收的变化方面使对治疗的响应量进行量化,以及相关的估计准确性。配对上行信息需要共同注册两组图像,这很可能在分析框架中引入错误登记错误。我们建议在量化分析中检验该误报的效果,其中我们制定了与古典(未配对)治疗评估的比较。我们证明了误报不应阻止基于配对的方法。特别是,即使对于大型典型的错误登记尺度,评估准确度的衍生测量仍然是强大的。该方法的可行性及其对预后效用的影响,通过多元COX存活分析进行了大量的50种Sarcoma研究的临床数据集,具有广泛的后续信息。令人鼓舞的结果表明这种方法可以概括对其他疾病和成像方式的分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号